The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer: A multi-institution study.
James Joseph Biagi
Research Funding - Sanofi
Ronald L. Burkes
Research Funding - Sanofi
Christine B. Brezden
Research Funding - Sanofi
Kevin M. Zbuk
Honoraria - Sanofi
Brandon Matthew Meyers
No relevant relationships to disclose
Oren Hannun Levine
No relevant relationships to disclose
Silvana Spadafora
No relevant relationships to disclose
Stephen Welch
No relevant relationships to disclose
Sukaina Davdani
No relevant relationships to disclose
Wilma Hopman
No relevant relationships to disclose
Christopher M. Booth
No relevant relationships to disclose
Rachel Anne Goodwin
No relevant relationships to disclose